Company / Interest Expense
Natera, Inc. Interest Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$4.1M
FY2025
5-year range
$4.1M / $15.1M
FY2021-FY2025
Trend
-61.9%
vs FY2024
Sector context
#39 of 43
Health Care
What the data says
Among 43 Health Care companies, Natera, Inc. is in the top 9% for interest expense. Interest Expense has declined for 3 consecutive years, from $15M in FY2022 to $4M in FY2025.
Based on SEC 10-K filings.
$4M in FY2025 with a 5-year CAGR of -17.2%.
Improved from $13M to $4M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -35.4%
- 5-Year CAGR
- -17.2%
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 43This company $4.1M Sector average $324.8M
▼
-98.7% below sector average
Key checks
Key Insights
- Natera, Inc.'s interest expense has declined for 3 consecutive years.
- 5-year CAGR of -17.2%, indicating a declining trend.
- In FY2025, interest expense decreased 61.9% year-over-year.
- Ranks #39 out of 43 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -11.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.1M | -61.9% |
| FY2024 | $10.7M | -15.5% |
| FY2023 | $12.6M | -16.2% |
| FY2022 | $15.1M | +81.6% |
| FY2021 | $8.3M | -20.7% |
| FY2020 | $10.5M | +148.7% |
| FY2019 | $4.2M | -59.8% |
| FY2018 | $10.5M | +148.7% |
| FY2017 | $4.2M | +690.4% |
| FY2016 | $533.0K | -84.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026